Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.24% | 1.47% | 6.94% | 10.68% | 7.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.24% | 1.47% | 6.94% | 10.68% | 7.64% |
| Cost of Revenue | 12.46% | -5.54% | 1.24% | 8.16% | 3.69% |
| Gross Profit | 4.30% | 6.09% | 10.55% | 12.25% | 10.00% |
| SG&A Expenses | 4.63% | -0.07% | 5.37% | 6.15% | 3.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.44% | -2.03% | 3.75% | 7.07% | 3.88% |
| Operating Income | 0.57% | 43.99% | 31.33% | 36.30% | 34.60% |
| Income Before Tax | 4.20% | 42.57% | 2.95% | 56.29% | 29.07% |
| Income Tax Expenses | 1.05% | 35.38% | 21.52% | 49.24% | 38.00% |
| Earnings from Continuing Operations | 5.22% | 44.90% | -2.08% | 58.39% | 26.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -72.03% | 419.51% | -1,965.00% | -623.81% | -29.67% |
| Net Income | 4.82% | 47.20% | -4.15% | 57.36% | 26.40% |
| EBIT | 0.57% | 43.99% | 31.33% | 36.30% | 34.60% |
| EBITDA | 0.37% | 22.33% | 53.65% | 31.08% | 30.12% |
| EPS Basic | 6.38% | 47.37% | -2.22% | 54.55% | 23.68% |
| Normalized Basic EPS | 5.41% | 45.22% | 2.52% | 52.24% | 26.38% |
| EPS Diluted | 6.38% | 47.37% | -2.22% | 54.55% | 23.68% |
| Normalized Diluted EPS | 5.41% | 45.22% | 2.52% | 52.24% | 26.38% |
| Average Basic Shares Outstanding | -1.47% | -0.11% | -1.97% | 1.82% | 2.20% |
| Average Diluted Shares Outstanding | -1.47% | -0.11% | -1.97% | 1.82% | 2.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |